Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Other Non-Current Assets (2024)

Updated

Adaptin Bio's Other Non-Current Assets was $193,876 in Q4 2024.

Analysis

Adaptin Bio (APTN) Other Non-Current Assets (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 15.10 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 10.73 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 4.75 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 9.94 Bn
10 Adaptin Bio 56.76 Mn 54.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 193,876.00
API Access

Adaptin Bio Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=APTN&period=max&api_key=YOUR_API_KEY